vs
Side-by-side financial comparison of SenesTech, Inc. (SNES) and 60 DEGREES PHARMACEUTICALS, INC. (SXTP). Click either name above to swap in a different company.
SenesTech, Inc. is the larger business by last-quarter revenue ($421.0K vs $303.4K, roughly 1.4× 60 DEGREES PHARMACEUTICALS, INC.). SenesTech, Inc. runs the higher net margin — -428.5% vs -474.2%, a 45.7% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -16.0%). SenesTech, Inc. produced more free cash flow last quarter ($-1.7M vs $-1.8M). Over the past eight quarters, 60 DEGREES PHARMACEUTICALS, INC.'s revenue compounded faster (69.4% CAGR vs 0.7%).
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
SNES vs SXTP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $421.0K | $303.4K |
| Net Profit | $-1.8M | $-1.4M |
| Gross Margin | 55.3% | 60.2% |
| Operating Margin | -446.8% | -632.0% |
| Net Margin | -428.5% | -474.2% |
| Revenue YoY | -16.0% | 25.6% |
| Net Profit YoY | -43.7% | 29.7% |
| EPS (diluted) | $0.48 | $-8.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $421.0K | $303.4K | ||
| Q3 25 | $690.0K | $437.6K | ||
| Q2 25 | $625.0K | $100.9K | ||
| Q1 25 | $485.0K | $163.6K | ||
| Q4 24 | $501.0K | $241.6K | ||
| Q3 24 | $482.0K | $135.3K | ||
| Q2 24 | $459.0K | $125.0K | ||
| Q1 24 | $415.0K | $105.7K |
| Q4 25 | $-1.8M | $-1.4M | ||
| Q3 25 | $-1.3M | $-2.3M | ||
| Q2 25 | $-1.6M | $-1.7M | ||
| Q1 25 | $-1.7M | $-1.9M | ||
| Q4 24 | $-1.3M | $-2.0M | ||
| Q3 24 | $-1.5M | $-2.2M | ||
| Q2 24 | $-1.6M | $-4.2M | ||
| Q1 24 | $-1.8M | $430.5K |
| Q4 25 | 55.3% | 60.2% | ||
| Q3 25 | 62.8% | -22.9% | ||
| Q2 25 | 65.4% | 50.4% | ||
| Q1 25 | 64.5% | 55.2% | ||
| Q4 24 | 60.9% | 51.1% | ||
| Q3 24 | 65.4% | 17.4% | ||
| Q2 24 | 54.2% | 28.3% | ||
| Q1 24 | 32.5% | 38.1% |
| Q4 25 | -446.8% | -632.0% | ||
| Q3 25 | -195.2% | -531.4% | ||
| Q2 25 | -258.2% | -1590.0% | ||
| Q1 25 | -342.9% | -1168.4% | ||
| Q4 24 | -250.9% | -854.7% | ||
| Q3 24 | -321.0% | -1566.0% | ||
| Q2 24 | -349.0% | -3351.8% | ||
| Q1 24 | -444.1% | -1270.4% |
| Q4 25 | -428.5% | -474.2% | ||
| Q3 25 | -188.1% | -529.3% | ||
| Q2 25 | -258.6% | -1717.7% | ||
| Q1 25 | -343.3% | -1147.4% | ||
| Q4 24 | -250.5% | -846.3% | ||
| Q3 24 | -313.9% | -1596.4% | ||
| Q2 24 | -345.1% | -3339.0% | ||
| Q1 24 | -441.4% | 407.4% |
| Q4 25 | $0.48 | $-8.26 | ||
| Q3 25 | $-0.28 | $-0.66 | ||
| Q2 25 | $-0.87 | $-1.25 | ||
| Q1 25 | $-1.28 | $-1.56 | ||
| Q4 24 | $-0.15 | $-51.96 | ||
| Q3 24 | $-2.07 | $-2.92 | ||
| Q2 24 | $-3.08 | $-21.12 | ||
| Q1 24 | $-3.56 | $1.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.6M | $2.8M |
| Total DebtLower is stronger | — | $150.0K |
| Stockholders' EquityBook value | $9.6M | $3.5M |
| Total Assets | $12.8M | $5.4M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $2.8M | ||
| Q3 25 | $10.2M | $4.1M | ||
| Q2 25 | $6.1M | $2.0M | ||
| Q1 25 | $1.7M | $3.5M | ||
| Q4 24 | $1.3M | $3.4M | ||
| Q3 24 | $2.5M | $5.0M | ||
| Q2 24 | $2.0M | $1.6M | ||
| Q1 24 | $3.6M | — |
| Q4 25 | — | $150.0K | ||
| Q3 25 | — | $150.0K | ||
| Q2 25 | — | $150.0K | ||
| Q1 25 | — | $150.0K | ||
| Q4 24 | — | $150.0K | ||
| Q3 24 | — | $150.0K | ||
| Q2 24 | — | $150.0K | ||
| Q1 24 | — | $150.0K |
| Q4 25 | $9.6M | $3.5M | ||
| Q3 25 | $11.3M | $4.4M | ||
| Q2 25 | $7.0M | $2.4M | ||
| Q1 25 | $2.9M | $4.1M | ||
| Q4 24 | $2.5M | $4.0M | ||
| Q3 24 | $3.7M | $6.0M | ||
| Q2 24 | $3.1M | $3.0M | ||
| Q1 24 | $4.6M | $7.2M |
| Q4 25 | $12.8M | $5.4M | ||
| Q3 25 | $14.6M | $6.7M | ||
| Q2 25 | $10.4M | $4.2M | ||
| Q1 25 | $3.6M | $6.0M | ||
| Q4 24 | $3.3M | $5.8M | ||
| Q3 24 | $4.4M | $7.4M | ||
| Q2 24 | $4.0M | $4.3M | ||
| Q1 24 | $5.5M | $8.4M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-1.7M |
| Free Cash FlowOCF − Capex | $-1.7M | $-1.8M |
| FCF MarginFCF / Revenue | -398.3% | -584.2% |
| Capex IntensityCapex / Revenue | 3.1% | 26.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.9M | $-7.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.7M | $-1.7M | ||
| Q3 25 | $-1.4M | $-2.1M | ||
| Q2 25 | $-1.1M | $-1.5M | ||
| Q1 25 | $-1.6M | $-1.6M | ||
| Q4 24 | $-1.2M | $-1.6M | ||
| Q3 24 | $-1.4M | $-1.7M | ||
| Q2 24 | $-1.6M | $-1.2M | ||
| Q1 24 | $-1.8M | $-1.1M |
| Q4 25 | $-1.7M | $-1.8M | ||
| Q3 25 | $-1.4M | $-2.1M | ||
| Q2 25 | $-1.2M | $-1.5M | ||
| Q1 25 | $-1.6M | $-1.6M | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-1.4M | $-1.7M | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $-1.8M | — |
| Q4 25 | -398.3% | -584.2% | ||
| Q3 25 | -205.9% | -484.2% | ||
| Q2 25 | -191.5% | -1483.6% | ||
| Q1 25 | -328.5% | -978.3% | ||
| Q4 24 | -246.1% | — | ||
| Q3 24 | -296.1% | -1252.8% | ||
| Q2 24 | -354.2% | — | ||
| Q1 24 | -441.2% | — |
| Q4 25 | 3.1% | 26.3% | ||
| Q3 25 | 6.1% | 2.3% | ||
| Q2 25 | 7.5% | 46.9% | ||
| Q1 25 | 7.4% | 1.6% | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 5.8% | 10.2% | ||
| Q2 24 | 8.5% | — | ||
| Q1 24 | 0.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -2.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
